Tag: Investigational New Drug Application

May 16, 2019

Cue Biopharma Announces FDA Acceptance of IND for Lead Immuno-oncology Candidate CUE-101

Cue Biopharma (NASDAQ:CUE) has announced that the US Food and Drug Administration (FDA) has accepted Cue Biopharma’s investigational new drug...
April 11, 2019

Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat

Albireo Pharma (NASDAQ:ALBO) has announced that its investigational new drug application (IND) cleared the 30-day review from the US Food...
December 3, 2018

4 Gene Therapy Companies to Watch

What gene therapy companies should be on investors' radar? Here are four promising companies to consider looking at in 2018.
July 2, 2018

4 Top Pharma Stocks on the TSX of Q2 2018

As investors look ahead to the remainder of 2018, we've put together a list of the top-gaining pharmaceutical stocks on...
June 7, 2018

MannKind Successfully Completes Phase 1 Trial of Treprostinil Technosphere

MannKind (Nasdaq:MNKD) announced that it has completed a Phase 1 clinical study of Treprostinil Technosphere (TreT) under an Investigational New...
May 24, 2018

Medicenna Receives Amendment to Revamp Clinical Trial

The Investing News Network had the opportunity to speak with Medicenna CEO Fahar Merchant at the Bloom Burton & Co....
May 10, 2018

MediciNova Announces Opening of Investigational New Drug Application for MN-166 (ibudilast) in Glioblastoma

MediciNova a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange...